一致Ｂ：2020年年度报告（英文版）.PDF

1、1 China National Accord Medicines Corporation Ltd.Annual Report 2020 April 2021 2 Section I.Important Notice,Contents and Interpretation Board of Directors,Supervisory Committee,all directors,supervisors and senior executives of China National Accord Medicines Corporation Ltd.(hereinafter referred t

2、o as the Company)hereby confirm that there are no any fictitious statements,misleading statements,or important omissions carried in this report,and shall take all responsibilities,individual and/or joint,for the reality,accuracy and completion of the whole contents.Lin Zhaoxiong,Principal of the Com

3、pany,Gu Guolin,person in charger of accounting works and Wang Ying,person in charge of accounting organ(accounting principal)hereby confirm that the Financial Report of 2020 Annual Report is authentic,accurate and complete.Other directors attending the Meeting for annual report deliberation except f

4、or the followed Name of director absent Title for absent director Reasons for absent Attorney Su Weiwei Independent Director Official business Chen Honghui The profit distribution plan that deliberated and approved by the Board is:based on total stock issued 428,126,983 shares,distributed 8.00 Yuan(

5、tax included)bonus in cash for every 10-share hold by all shareholders,0 shares bonus issued(tax included)and no capitalizing of common reserves carried out.3 Contents Section I Important Notice,Contents and Interpretation.2 Section II Company Profile and Main Financial Indexes.5 Section III Summary

6、 of Company Business.11 Section IV Discussion and Analysis of the Operation.15 Section V Important Events.44 Section VI Changes in shares and particular about shareholders.79 Section VII Preferred Stock.90 section VIII Convertible Bonds.91 Section IX Particulars about Directors,Supervisors,Senior Ex